Pulkit Gupta

Critic
DISC Type : C

Executive Director, Lilly Ventures at Eli Lilly and Company

Cambridge, Massachusetts, United States

Overview

Pulkit Gupta is an Executive Director at Lilly Ventures, where he leads the external innovation process on the US East Coast. With over a decade of experience spanning research, business development, and ventures, he specializes in small molecule and antibody discovery. He holds a Ph. D. in molecular biology from the University of Illinois Chicago.


He actively contributed to the characterization of Zinplava™ (bezlotoxumab), a monoclonal antibody for preventing recurrent C. difficile infections.

Personality Overview

Critic

Precise

Negotiator

They like to take decisions independently and do not seek others' support often.  It is very likely that they will negotiate pricing or other important terms. Unless the value is proven by data, they are unlikely to value fancy features.

Topics They Care About

Oncology Investing
Serves as a board observer for multiple oncology-focused companies, including Crossbow Therapeutics, HiberCell, and Mariana Oncology, indicating a strong focus on cancer therapeutics.
Venture Science
His role focuses on leading external innovation and venture science, bridging scientific discovery with investment strategy for Eli Lilly.
Novel Drug Platforms
His board observer role at Orbis Medicines, a company developing oral macrocycle drugs, shows an interest in innovative therapeutic technologies beyond traditional small molecules.

Media Appearances

Pulkit has no verified media appearances

Work History

3-2024
Executive Director, Lilly Ventures at Eli Lilly and Company
2-2022 - 3-2024
Senior Director, Venture Science, Business Development at Eli Lilly and Company
1-2025
Board Observer at Orbis Medicines
6-2023
Board Observer at Crossbow Therapeutics, Inc
4-2023
Board Observer at HiberCell

Education

2008 - 2013
Ph.D. from University of Illinois Chicago
2004 - 2008
B.Tech from Kurukshetra University

More Information

Social Presence :

Prographics :

Exp : 3 Location : Cambridge, Massachusetts, United States Job Level : Senior Designation : Executive Director, Lilly Ventures at Eli Lilly and Company
URL has been copied!

Insights For Selling To Pulkit

During A Call Or A Meeting

DO's

  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Be formal and objective, they will appreciate it more
  • Keep some extra margin while sharing pricing, they are likely to negotiate later

DONT's

  • Don’t rush them till they have clearly gotten all the necessary information
  • Don’t try to give too many examples of other users, they like to make their own decisions
  • Don’t try too hard to build a relationship with them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Pulkit is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Pulkit

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Pulkit move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Pulkit take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Pulkit

Personality Compatibility


Other Eli Lilly and Company Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.